Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: Post-approval Japanese population experience

Toshio Shimizu, Taroh Satoh, Kenji Tamura, Tomohiro Ozaki, Isamu Okamoto, Masahiro Fukuoka, Kazuhiko Nakagawa

Research output: Contribution to journalArticle

21 Citations (Scopus)

Fingerprint Dive into the research topics of 'Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: Post-approval Japanese population experience'. Together they form a unique fingerprint.

Medicine & Life Sciences